Cataract surgery is the most common surgical intervention worldwide.
Post-surgery management of patients is key to preventing infection and treating inflammation. An additional key priority for the surgeon is to help the patients quickly recover their vision.
NTC has developed an innovative drug to appropriately manage the prevention of infection and to treat inflammation in patients after cataract surgery. In addition, NTC offers new products aimed at quickly restoring patients’ visual acuity after surgery (see section “Corneal edema”).
LEGENDA

DROPS

SINGLE PACKED GAUZE

SINGLE DOSE

EYE COMPRESS

PRESERVATIVE FREE

MULTI DOSE

MEDICAL DEVICE

PATCH

IRIDYA
NTC portfolio in Eye Surgery
BLEFASTOP
Hy-Ter 5% (Hyaluronic acid +Tea tree oil), Aloe barbadensis


Hy-Ter 5% (Hyaluronic acid +Tea tree oil), Aloe barbadensis


TIABLO
Tiab 1% (Titanium+Silver), Xanthan gum, Dimethicone

Tiab 1% (Titanium+Silver), Xanthan gum, Dimethicone

IMPERIAL PURO
HA 0.2% w/o phosphates





HA 0.2% w/o phosphates





PUROFLOG
Ectoin® 2%, Hydroxyethyl cellulose 0.8%




Ectoin® 2%, Hydroxyethyl cellulose 0.8%




SKUDO
Ocular patch with aeration holes, hypoallergenic
and self-adhesive, double sterilization


Ocular patch with aeration holes, hypoallergenic
and self-adhesive, double sterilization

